Breaking News|Top Minimally Invasive Specialist Prof. Zhang Kaixian Joins Wuwei Cancer Hospital!
Breaking News|Top Minimally Invasive Specialist Prof. Zhang Kaixian Joins Wuwei Cancer Hospital!
Prestigious Collaboration, Building a New Chapter in Healthcare
To comprehensively enhance the level of minimally invasive tumor diagnosis and treatment and promote high-quality regional medical development, Wuwei Cancer Hospital has officially appointed Professor Zhang Kaixian, a renowned domestic expert in minimally invasive tumor therapy from Tengzhou Central People's Hospital, as a visiting professor of our hospital’s Minimally Invasive Cancer Treatment Center! This collaboration marks a new phase for our hospital in the field of precise and minimally invasive tumor therapy, providing patients with more advanced and high-quality diagnostic and treatment services.

Leading by Top Experts, Empowering Disciplinary Advancement
Professor Zhang Kaixian is a leading figure in the field of minimally invasive tumor therapy. Currently serving as Director of the Oncology Center at Tengzhou Central People's Hospital, he also holds key positions including Committee Member of the Minimally Invasive Therapy Committee of the Chinese Anti-Cancer Association and Vice Chairman of the Shandong Medical Association's Tumor Minimally Invasive Branch. With nearly 30 years of expertise in interventional oncology, microwave ablation, radioactive seed implantation, and other minimally invasive techniques, he has performed over 10,000 procedures. His team has achieved multiple technological breakthroughs in minimally invasive diagnosis and treatment of lung cancer, liver cancer, thyroid nodules, and other conditions, earning provincial Science and Technology Progress Awards for the team's innovations. Professor Zhang's appointment will bring cutting-edge techniques and innovative approaches to our hospital's Minimally Invasive Tumor Treatment Center, accelerating advancements in complex tumor cases, multidisciplinary team (MDT) collaboration, and clinical research.

Powerhouse Collaboration, Building a Regional Hub for Minimally Invasive Therapy
Wuwei Cancer Hospital Minimally Invasive Tumor Treatment Center has always adhered to its core philosophy of "precision, minimally invasive techniques, efficiency, and humanistic care." Equipped with internationally advanced systems such as DSA interventional systems, radiofrequency ablation devices, hyperthermic perfusion chemotherapy machines, and radioactive seed treatment planning systems, the center has mastered specialized techniques including tumor vascular intervention, microwave ablation, radioactive seed implantation, and hyperthermic perfusion chemotherapy. Through this in-depth collaboration with Professor Zhang Kaixian’s team, both parties will focus on advancing three key initiatives:

1.Technological Advancements: We have introduced cutting-edge technologies including: Multimodal ultrasound/CT-guided tumor ablation for complex anatomical sites, 3D template-guided precision particle implantation, Percutaneous Vertebroplasty (PVP). Our image-guided minimally invasive tumor therapies now feature: 3D-printed template-guided radioactive seed implantation, Microwave ablation combined with bone cementoplasty for spinal metastases, Microwave ablation with Reinforced Cementoplasty (RCC) for bone metastases, Concurrent biopsy and microwave ablation for small malignant pulmonary nodules.
2. Discipline Co-development: Expert-led surgical demonstrations, Multidisciplinary consultation for complex cases, Academic lecture series, Establishment of standardized minimally invasive diagnosis and treatment protocols.
3. Research Innovation: Joint application for national/provincial-level research projects on minimally invasive oncology, Translation of clinical techniques into research achievements, Promotion of evidence-based medical practices.
Centered on patients, Illuminate New Hope of life
"Minimally invasive therapy represents the inevitable future of oncology—delivering precise tumor ablation while optimally preserving patients' organ function," stated Professor Zhang Kaixian. "I will collaborate closely with Wuwei Cancer Hospital's team to bring cutting-edge minimally invasive technologies to patients' doorsteps."

Future Outlook
With the addition of Professor Zhang Kaixian's team, Wuwei Cancer Hospital will leverage its Minimally Invasive Oncology Center as a platform to: strengthen collaborations with China's top-tier medical institutions, accelerate clinical adoption of innovative therapies and advanced technologies, deliver more efficient and patient-centered care to oncology patients across the Hexi Corridor and Northwest China.
Consultation hotline for Minimally Invasive Oncology Center: 0935-6989702
Address: First Floor, Building 7, Inpatient Department, Heavy Ion District, Gansu Wuwei Cancer Hospital
Virtue Refines Expertise, Steadfast Practice Achieves Excellence
Wuwei Cancer Hospital remains steadfast in its mission to safeguard public health, soaring on the dual wings of expert empowerment and technological innovation, as it diligently writes Wuwei's chapter in the "Healthy China" initiative!
Tumor Minimally Invasive Treatment Center
Discipline Introduction
As the benchmark for oncological care in Wuwei, Gansu Province, the Minimally Invasive Therapy Center at Wuwei Cancer Hospital adheres to a "patient-centered, technology-driven" philosophy. Leveraging state-of-the-art equipment, elite medical teams, and extensive clinical expertise, we have established a comprehensive oncology platform integrating minimally invasive intervention, precision treatment, and enhanced recovery after surgery. At this inaugural stage, our center is launching advanced minimally invasive technologies including: hyperthermic Intraperitoneal Chemotherapy, High-Intensity Focused Ultrasound (HIFU, "Haifu Knife"), radiofrequency Ablation (RFA), these cutting-edge modalities deliver safer, more effective treatment options for cancer patients.

Professional Characteristics
1. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) – The "Thermal Revolution" in Oncology
For peritoneal metastases (e.g., gastric/ovarian cancers), our center pioneers HIPEC. This technology circulates precision-temperature-controlled (42-43°C) chemotherapeutic agents directly into the abdominal cavity, where hyperthermia enhances drug penetration and eradicates free cancer cells while minimizing systemic toxicity. Compared to conventional therapies, HIPEC offers: Minimal invasiveness, Localized high drug concentration, Superior recurrence prevention. Particularly effective for palliative care and postoperative adjuvant therapy in advanced-stage patients.
2. High-Intensity Focused Ultrasound (HIFU, "Haifu Knife") – The "Invisible Scalpel" for Non-Invasive Ablation
This focused ultrasound technology delivers 60-100°C thermal energy to precisely target tumors without incision or radiation damage. Proven effective for: Liver/pancreatic cancers, Uterine fibroids, Patients achieve rapid recovery (ambulatory within 24 hours) with significantly improved comfort.
3. Radiofrequency Ablation (RFA) – "Precision Strike" Through Micro-Incision
Under imaging guidance, RFA needles percutaneously deliver high-frequency currents to induce tumor necrosis. Key applications:
• Curative treatment for early-stage lung/liver/thyroid cancers
• Needle-sized entry points with minimal scarring
Our personalized protocols provide new options for elderly patients or those with comorbidities ineligible for traditional surgery.
Expert team
The department has an expert team composed of chief physicians, associate chief physicians, and attending physicians, who possess extensive clinical experience and profound academic accomplishments. The team boasts strong technical skills and advanced diagnostic and treatment capabilities. Additionally, our department has invited Professor Zhang Kaixian, Chief Physician of the Comprehensive Oncology Department at Tengzhou Central People's Hospital, to serve as a visiting professor. He specializes in image-guided minimally invasive tumor therapy and has pioneered several techniques in China, including: 3D-printed non-small nodule precision puncture biopsy, dosimetry studies on esophageal radioactive seed stents, microwave ablation combined with bone cementoplasty for vertebral metastases, 3D-printed coplanar template-guided radioactive seed implantation. He has participated in 6 national and provincial multicenter research projects, led 1 Shandong Province multicenter study, published over 20 academic papers (including 7 SCI-indexed articles), and received 5 Zaozhuang City Science and Technology Progress Awards.
Service philosophy
The department adheres to a "patient-centered" service philosophy, prioritizing patient experience and satisfaction. We provide a warm and comfortable medical environment along with efficient and convenient treatment processes. Additionally, the department conducts health education initiatives to enhance public awareness and prevention knowledge about cancer.